ResMed Inc. RMD NYSE

ResMed Inc. (RMD) reported total assets of $8.5B and total liabilities of $2.18B for quarter ending 2025-12-31, resulting in total equity of $6.32B.

The company held $1.43B in cash and short-term investments. Total debt stood at $1B, with net debt of $-415.22M. The Debt-to-Equity (D/E) ratio was 0.16 (conservative).

Current ratio is 3.06, indicating strong short-term liquidity. Interest coverage is 62.6x (strong).

Criteria supported by this page:

• HEALTH (100/100, Pass) — Debt-to-Equity of 0.16, current ratio of 3.06, interest coverage 62.6x — balance sheet is strong
• MOAT (80/100) — Total assets $8.5B and equity $6.32B support the company's competitive scale
• VALUE (48/100) — Debt-to-Equity 0.16 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 78/100 with 5/7 criteria passed.